Full Text
The potential cardiovascular risk of rosiglitazone comparing to other anti-diabetes agents- A retrospective descriptive study

Abstract

Authors

Y Deng J.J. Guo A.C. Lin

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×